Why some companies ban secondary sales entirely, and what sellers do anyway

Most companies discussed elsewhere on this site tolerate, and often actively organize, secondary liquidity for their shareholders. A meaningful minority take the opposite approach: strict transfer restrictions with little to no ROFR waivers, no tender program, and an explicit unwillingness to approve outside buyers under almost any circumstance. That policy doesn't stop demand for liquidity — it just pushes it into less visible, riskier channels.

Why a company would choose this stance

Reasons vary: a company deep in sensitive fundraising or acquisition talks may not want its cap table disclosed or disrupted; a founder with strong control preferences may simply dislike outside shareholders they didn't personally choose; and some companies worry that visible secondary pricing — especially a discounted print — could complicate their own next primary round's valuation narrative. Whatever the specific reason, the effect is the same: sellers who need liquidity have no company-sanctioned path to get it.

The gray-market workarounds that emerge anyway

Where a legitimate path doesn't exist, informal ones sometimes do. Sellers occasionally structure arrangements as forward contracts that don't require immediate transfer (though many companies' agreements restrict these too), or enter side letters with a prospective buyer promising to cooperate on a future transfer if and when the company ever relents. Some sellers simply attempt an unauthorized transfer and accept the risk that the company refuses to record it on the cap table — a genuinely risky position that can leave a buyer holding an economic claim with no enforceable ownership.

Why these workarounds are worse for everyone

A gray-market transaction lacks the standardized paperwork, KYC/AML checks, and — critically — the company cooperation that make a legitimate secondary sale enforceable. A buyer in this position has materially less protection than one using a marketplace or a company-sanctioned tender, and a seller risks violating their own agreements with the company, jeopardizing future equity grants or even employment in serious cases.

What this means in practice

A company's transfer-restriction posture is worth understanding well before agreeing to any deal terms — see why company consent is the real gatekeeper in every secondary sale for how that leverage typically gets used, and treat any proposed workaround around a strict no-transfer policy as meaningfully higher risk than a standard, company-approved transaction.